Intracellular recording methods with "sharp" microelectrodes were used to study actions of bradykinin (BK) on electrical behavior of morphologically identified neurons and the identification and localization of BK receptors in the submucosal plexus of guinea pig small intestine. Exposure to BK depolarized the membrane potential and elevated excitability in submucosal neurons with AH-type electrophysiological behavior and Dogiel II multipolar morphology and in neurons with S-type electrophysiological behavior and uniaxonal morphology. BK-evoked depolarizing responses were associated with increased neuronal input resistance in AH-type neurons and decreased input resistance in S-type neurons. -BK mimicked the excitatory action of BK. Western blot analysis and reverse transcription-polymerase chain reaction confirmed the expression of B 2 receptor protein and mRNA. Binding studies with a fluorescently labeled BK 2 antagonist found expression of B 2 receptors on a majority of the ganglion cells. B 2 receptors occupied 82% of the neurons that expressed immunoreactivity for neuropeptide Y, 75% of the neurons that expressed vasoactive intestinal peptide, 84% of the neurons that expressed substance P, 71% of the neurons that expressed choline acetyltransferase, and all neurons that expressed calbindin immunoreactivity. The results suggest that the B 2 receptor mediates the excitatory action of BK on submucosal plexus neurons. Pathophysiological significance of the excitatory actions on secretomotor neurons might be stimulated mucosal secretion and the secretory diarrhea associated with intestinal inflammatory states.
-BK mimicked the excitatory action of BK. Western blot analysis and reverse transcription-polymerase chain reaction confirmed the expression of B 2 receptor protein and mRNA. Binding studies with a fluorescently labeled BK 2 antagonist found expression of B 2 receptors on a majority of the ganglion cells. B 2 receptors occupied 82% of the neurons that expressed immunoreactivity for neuropeptide Y, 75% of the neurons that expressed vasoactive intestinal peptide, 84% of the neurons that expressed substance P, 71% of the neurons that expressed choline acetyltransferase, and all neurons that expressed calbindin immunoreactivity. The results suggest that the B 2 receptor mediates the excitatory action of BK on submucosal plexus neurons. Pathophysiological significance of the excitatory actions on secretomotor neurons might be stimulated mucosal secretion and the secretory diarrhea associated with intestinal inflammatory states.
Chemical signaling is a mode of physiological communication between the enteric nervous system (ENS) and the enteric immune system (Wood, 2002) . Neural networks in the myenteric and submucosal plexuses of the ENS interact to form an independent integrative nervous system that controls intestinal motility, secretion, and blood flow and interact to organize the activity of each of the three effector systems into functional patterns of digestive behavior (Wood, 1994a; Gershon, 1998; Wood et al., 1999) . In so doing, the ENS functions in interactive concert with the enteric immune system. Populations of immune/inflammatory cells (lymphocytes, granulocytes, and mast cells) surround the ENS and expand in number during pathological inflammatory states (e.g., enteric infections, inflammatory bowel disease, and radiation-induced enteritis). Members of the immune/inflammatory cell populations communicate with the ENS in paracrine manner through the release of chemical mediators (Frieling et al., 1994; Wood, 2002; Liu et al., 2003a) . Exposure to the inflammatory mediators histamine, mast cell proteases, prostaglandins, leukotrienes, and cytokines modifies both neuronal excitability and neurotransmission (Nemeth et al., 1984; Frieling et al., 1994; Dekkers et al., 1997; Xia et al., 1999; Gao et al., 2002; Liu et al., 2003a,b) .
The present study was focused on bradykinin (BK) as one of the putative mediators formed during inflammatory, ischemic, and hemorrhagic states in the bowel (Zeitlin and Smith, 1973; Brown and Roberts, 2001) . It was the second phase of a project to understand how BK formation might alter gut motility and secretion through actions in the ENS. The second phase aimed to study the cellular neuropharmacology of BK on neuronal elements of the submucosal plexus with a view toward potential pathological influence on intestinal secretory function. The earlier phase investigated actions, mechanisms of action, and localization of action to specific categories of neurons in the myenteric division of the ENS (Hu et al., 2003) . Acquisition of information for each of the two plexuses individually was advised because the functional neurobiology differs for each plexus. Examples of differences include the segregation of motor neurons and specific reflex behaviors between the two plexuses. Excitatory and inhibitory musculomotor neurons are located in the myenteric plexus, and secretomotor neurons are in the submucosal plexus. Reflex circuits for propulsive motility are "hardwired" into the myenteric plexus (Smith et al., 1990; Kunze and Furness, 1999) . Reflex circuitry for the control of intestinal secretion is incorporated in the neural networks of the submucosal plexus (Frieling et al., 1992; Cooke, 2000) . Earlier studies in the myenteric plexus found excitatory actions of BK on neurons with AH-type 2 electrophysiological behavior, Dogiel type II multipolar morphology, and immunoreactivity for calbindin and on neurons with S-type electrophysiological behavior, uniaxonal Dogiel type I morphology and immunoreactivity for nitric-oxide synthase (Hu et al., 2003) . Calbindin-positive Dogiel type II neurons predominate in the myenteric plexus and are scarce in the submucosal plexus (Brookes 2001a,b) . Nitric oxide-positive uniaxonal neurons that express nitric-oxide synthase and project their axon in the aboral direction within the myenteric plexus are identified as inhibitory motor neurons to the musculature (Brookes, 2001a,b) . Stimulation of excitability in this neuronal population suppresses contractile activity. A subpopulation of uniaxonal neurons that express immunoreactivity for choline acetyltransferase, neuropeptide Y, and vasoactive intestinal peptide in the submucosal plexus are identified as secretomotor neurons (Bornstein and Furness, 1988) . Elevated activity in this neuronal population increases mucosal secretion of H 2 O and electrolytes, which when exaggerated, leads to neurogenic secretory diarrhea (Cooke, 1994) . One of the aims of the present study was to evaluate actions of BK on secretomotor neurons in the submucosal plexus.
Bradykinin B 1 and B 2 receptors mediate the actions of BK. Both receptors have been defined pharmacologically by use of specific peptide and nonpeptide antagonists. DNA that encodes functional BK B 2 receptors from human, rat, rabbit, mouse, and guinea pig sources have been cloned (McEachern et al., 1991; Hess et al., 1992; Ma et al., 1994; Bachvarov et al., 1996; Farmer et al., 1998) . Bradykinin binds preferentially to the B 2 BK receptor and the related kinins generated by cleaving the terminal arginine residue from kallidin and BK (e.g., des-arg 10 -kallidin, and des-arg 9 -bradykinin) bind preferentially to the BK B 1 receptor. An aim of the present study was to identify the kind of BK receptor expressed by neurons in the submucosal plexus.
Materials and Methods
Adult male Hartley-strain guinea pigs (300 -350 g) were stunned by a sharp blow to the head and exsanguinated from the cervical vessels according to protocols approved by The Ohio State University Laboratory Animal Care and Use Committee and United States Department of Agriculture Veterinary Inspectors. Submucosal plexus preparations were obtained from segments of small intestine removed 10 to 20 cm proximal to the ileocecal junction. The segments were microdissected for electrophysiological recording and fluorescence immunohistochemistry as described previously (Frieling et al., 1991) .
Electrophysiology. The preparations were placed in 2-ml chambers and superfused with Krebs' solution warmed to 37°C and gassed with 95% O 2 , 5% CO 2 (pH 7.3-7.4), at a rate of 10 to 15 ml min Ϫ1 . The composition of the Krebs' solution was 120 mM NaCl, 6 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgCl 2 , 1.35 mM NaH 2 PO 4 , 14.4 mM NaHCO 3 , and 11.5 mM glucose. Transmembrane electrical potentials were recorded with conventional "sharp" intracellular microelectrodes filled with 4% biocytin (Sigma-Aldrich, St. Louis, MO) in 2 M KCl or potassium acetate containing 0.05 M Tris buffer (pH 7.4) and having resistances of 80 to 200 M⍀. Methods for electrophysiological recording of electrical behavior in submucosal neurons and procedures for development of the intraneuronal marker biocytin were the same as described previously (Liu et al., 2003a) .
Reverse Transcriptase-Polymerase Chain Reaction. Total RNA was extracted from submucosal plexus preparations with TRIzol (Invitrogen, Carlsbad, CA). Reverse transcription (1 g of RNA) was performed by adding the following and incubating at 42°C for 60 min: 2.0 l of 10ϫ RT buffer (0.1 M Tris, 0.5 M KCl, pH 8.3), 4.0 l of 25 mM MgCl 2, 2.0 l of deoxynucleotide mix (dATP, dCTP, dGTP, and dTTP, each at 10 mM), 2.0 l of oligo-p(dT) primer (0.8 g/l), 50 units of RNase inhibitor, 20 units of avian myeloblastosis virus reverse transcriptase (Roche Diagnostics, Indianapolis, IN), and 1 l of total RNA. Heating to 99°C for 5 min and then cooling to 4°C for 5 min deactivated the enzyme. The following reaction mixture was added to 5 l of the cDNA product: 25 l of PCR master mix (Roche Diagnostics), 2.0 l of primers, and 18 l of PCR grade sterile water. The primers used were as follows.
1. Upstream: 5Ј-CGTTCTTGTGGGTCCTGTTT-3Ј 2. Downstream 5Ј-CAGGAGGACATTGGTGAACA-3Ј 3. Upstream: 5Ј-TATTCCTGGTGGTGGCTATC-3Ј 4. Downstream: 5Ј-GGAGGCTACCAGTGTGAGGA-3Ј Primers 1 and 2 were designed from the mRNA of a guinea pig BK B 2 receptor (GenBank accession no. AJ003243) to amplify a 500-base pair fragment. Primers 3 and 4 were a pair of degenerate primers used to amplify a 401-base pair fragment for the guinea pig BK B 1 receptor. Primers 3 and 4 were made from the conserved region between mouse BK B 1 receptor (GenBank accession no. NM_007539) and rat BK B 1 receptor (GenBank accession no. U66107). Amplification was done with an iCycler (Bio-Rad, Hercules, CA). PCR cycles consisted of denaturation for 1 min at 94°C, annealing at 56°C for 90 s, and extension at 72°C for 90 s. A total of 30 cycles was followed by completion of extension for 7 min at 72°C. PCR product (12 l) was analyzed by electrophoresis on 2% agarose gel. Sequencing was done with an ABI 373XL DNA sequencer after the PCR product was purified with Qiaquick PCR purification kit (QIAGEN, Valencia, CA). RT-PCR without avian myeloblastosis virus reverse transcriptase was used as a negative control.
Western Blot. Submucosal plexus preparations were prepared as described above, washed in cold Krebs' solution, and stored at Ϫ70°C. The Complete Mini kit (Roche Diagnostics) was used to obtain samples of total submucosal plexus protein. Samples of total protein (20 -100 g) were loaded onto 11% sodium dodecyl sulfate polyacrylamide gels and blotted onto nitrocellulose filters. The filters were incubated with antiserum in buffer containing 5% nonfat dairy milk for 4 h at room temperature. A rabbit polyclonal antibody specific for the B 1 bradykinin receptor (1:100, code SC-15048; Santa Cruz Biotechnology Inc., Santa Cruz, CA) or a monoclonal B 2 receptor antibody (1:1000 code: 610451; BD Transduction Laboratories, San Diego, CA) was used. The filters were then incubated with goat anti-rabbit or goat anti-mouse horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. Antibody labeling was detected by chemiluminescence. Color molecular weight standards were run on each gel.
Immunohistochemistry. Whole-mounts of the submucosal plexus were incubated in 10% normal horse serum in PBS for 1 h at room temperature before exposure to the primary antisera diluted in hyper- jpet.aspetjournals.org tonic PBS containing 10% normal horse serum, 0.3% Triton X-100, and 0.1% sodium azide. The preparations were placed in humidified chambers and processed for indirect single or double immunofluorescence staining by incubation for 18 h at room temperature in rabbit or mouse antiserum or a mixture of primary antibodies from different species to achieve double labeling. The primary antibodies used were mouse anti-B 2 receptor (1:1000) (code 610451; BD Transduction Laboratories), rabbit anti-B 2 receptor (1:1000) (code AS276; kindly provided by Prof. Mü ller-Esterl, Frankfurt, Germany), mouse anti-HuC/HuD neuronal protein (1:200) (code A21271; Molecular Probes, Eugene, OR), goat anti-choline acetyltransferase (ChAT) (1:100) (code AB 144P; Chemicon International, Temecula, CA); sheep anti-neuropeptide Y (NPY) (1: 3000) (code AB1583; Chemicon International), rat anti-substance P (SP) (1:200) (code MAB356; Chemicon International), rabbit anti-vasoactive intestinal peptide (VIP) (1:100) (code IHC7161; Peninsula Laboratories, Belmont, CA), and goat anti-calretinin (1:5000) (code AB1550; Chemicon International). The preparations were incubated for 24 h in the primary antibody at room temperature followed by 3 ϫ 1-min washes with PBS and then incubated in fluorescein isothiocyanatelabeled donkey anti-rabbit secondary IgG (code 711-095-152), donkey anti-sheep secondary IgG (code 713-095-147), donkey anti-rat secondary IgG (code AP189F) or donkey anti-goat secondary IgG (code 705-095-147), and Cy3-labeled donkey anti-rabbit secondary IgG (code 711-165-152) or donkey anti-mouse secondary IgG (code 715-165-150) for another 30 min at 37°C followed by 3 ϫ 10-min washes with PBS. All secondary antibodies were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA). The preparations were cover-slipped in Vectorshield (Vector Laboratories, Burlingame, CA). Fluorescent labeling was examined with a Nikon Eclipse E-600 fluorescent microscope that was equipped with appropriate filters and a SPOT-2 chilled color and B/W digital camera (Diagnostic Instruments, Sterling Heights, MI). Data Analysis. Data are presented as means Ϯ S.E.M. Concentration-response curves were constructed using the following leastsquares fitting routine.
, where V is the observed membrane depolarization, V max is the maximal response, C is the corresponding drug concentration, EC 50 is the concentration that evoked a half-maximal response, and n H is the apparent Hill coefficient. Antagonist concentration-inhibition curves were obtained in individual cells by using a fixed concentration of BK (30 nM), and progressively increasing the concentration of antagonist. IC 50 values were calculated by least-squares fitting to the following
ϪnH ], where V is the observed percentage of inhibition and V max is peak percentage of inhibition, [Ant] is the corresponding antagonist's concentration, IC 50 is the antagonist concentration that produced half-maximal inhibition of BK-evoked responses, and n H is the apparent Hill coefficient. The graphs in the figures were drawn by averaging results from all experiments and fitting a single concentration-response curve to the pooled data with SigmaPlot software (SPSS Science Inc., Chicago, IL). All EC 50 and IC 50 values are the mean Ϯ S.E.M.
Results

Identification of the Submucosal B 2
Receptor. An RT-PCR product with 500 nucleotide base pairs was amplified by a pair of specific primers for the guinea pig BK B 2 receptor (Fig. 1A, lane 2) . No RT-PCR product was amplified for the B 1 receptor (Fig. 1A, lane 3) . The nucleotide sequence for the RT-PCR product was purified and sequenced. The sequence aligned with that of guinea pig lung BK B 2 receptor cDNA. There was complete identity with the corresponding region of the guinea pig lung B 2 receptor (from 245 to 744) (GenBank accession no. AJ 003243).
Western blot analysis was used to identify the presence of B 2 receptor protein in submucosal protein extracts. A mouse anti-B 2 receptor antibody recognized a protein band of 42 kDa in guinea pig submucosal protein extracts (Fig. 1B, lane  2) . The positive control (Fig. 1B, lane 3) was obtained from a rat pituitary protein extract. The difference in molecular mass of 3 kDa between the rat and guinea pig BK B 2 receptor accounts for differences seen on Western blots (SWISS-PROT; O70526 for guinea pig and P25023 for rat). Expression of B 1 receptor protein was not detected in submucosal plexus extracts (Fig. 1B, lane 1) .
BODIPY 576/579 is a commercially available fluorescent probe that can be bound to a variety of compounds, including the selective BK B 2 receptor antagonist HOE-140. HOE-741 is the BODIPY 576/579 tagged form of HOE-140. We used 30 nM HOE-741 as a tool for localizing BK B 2 receptors in submucosal ganglia (Fig. 2A) . Pretreatment with 300 nM HOE-140 for 40 min before application of HOE-741 for 40 min quenched fluorescent labeling by HOE-741 and enhanced confidence in HOE-741 selectivity for labeling of cells that expressed BK B 2 receptors (Fig. 2B) . Fluorescent labeling with HOE 741 was localized exclusively to ganglion cell somas and a limited number of neuronal processes (Fig. 2A) . The specific neuronal localization was confirmed by double labeling with anti-HuC/HuD neuronal protein mouse monoclonal antibody that has been shown to label all enteric neurons Lin et al., 2002) (Fig. 2C) .
The chemical codes for submucosal neurons with BK B 2 receptors were studied by double labeling HOE-741 with immunoreactivity for ChAT, NPY, VIP, calretinin, calbindin, or SP. HOE-741 fluorescence was found in 82.4% (1103/1339) of the ganglion cells associated with NPY immunoreactivity (Fig. 2, D-F) . Analysis with a monoclonal bradykinin B 2 receptor antibody generated a 42-kDa band. Lane 3 is a positive B 2 receptor control obtained for rat pituitary gland. The known difference in molecular mass of 3-kDa between the rat and guinea pig BK B 2 receptor accounts for differences between lanes 2 and 3. 
Downloaded from
Most of the neurons (74.6%; 1894/2540) with immunoreactivity for VIP also expressed the B 2 receptor (Fig. 2, G-I) . A large number of SP-immunoreactive neurons (83.6%; 424/ 507) and all calbindin-immunoreactive neurons were labeled by HOE-741 and 70.5% (2403/3409) of the ChAT-immunoreactive neurons were labeled with HOE-741. Colocalization of HOE-741 binding with calretinin immunoreactivity was not found (data not shown).
Indirect immunofluorescence with a mouse anti-B 2 receptor antibody (code 610451; BD Transduction Laboratories) was used to study the distribution pattern of the BK B 2 receptor and as a control for the results with HOE-741. The distribution pattern for the B 2 receptor with the anti-B 2 receptor antibody was similar to that found with HOE-741 (Fig. 3) . All NPY neurons (n ϭ 2135) expressed BK B 2 receptor immunoreactivity (Fig. 3, A-C) . NPY-immunoreactive neurons are known to be a subset of cholinergic neurons in the guinea pig submucosal plexus (Brookes, 2001a,b) . Double labeling of BK B 2 receptor immunoreactivity with immunoreactivity for ChAT and VIP showed localization of the B 2 receptor with both ChAT-(data not shown) and VIP-positive neurons (Fig. 3, D-F) . Ninety-nine percent of neurons in guinea pig submucosal ganglia express ChAT or VIP (Brookes, 2001a,b) . Our finding that the BK B 2 receptor is colocalized with both ChAT and VIP might suggest that 99% of the neuronal population in the submucosal plexus express the B 2 receptor.
As a separate control, we also used a rabbit polyclonal B 2 receptor antibody (code AS276) that was characterized by Reyes-Cruz et al. (2000) . The same immunostaining pattern for distribution of the B 2 receptor was obtained with this antibody as with the mouse antibody described above (data not shown).
Electrophysiology. Submucosal neurons were classified as AH-or S-type based on generally accepted criteria (Bornstein et al., 1994; Wood, 1994a) . Application of BK (0.3-300 nM) by addition to the superfusion solution for 50 s evoked a concentration-dependent depolarization of the membrane potential coincident with enhanced excitability in 23 of 26 AHtype neurons and 59 of 71 S-type neurons (Fig. 4A) . Depolarizing responses in AH-type neurons were associated with an increase in neuronal input resistance and with decreased input resistance in S-type neurons. The electrophysiological results were consistent with the histological finding that most submucosal ganglion cells express the BK receptor. The depolarizing responses began after a 5-to 10-s delay and peaked in 2.5 to 3 min. Enhanced excitability was reflected by an increased number of action potentials evoked by intraneuronal injection of constant current depolarizing pulses, anodal break excitation at the offset of hyperpolarizing current pulses, and the occurrence of spontaneous spike discharge. Suppression of the characteristic hyperpolarizing after-potentials in AH-type neurons was another action of BK (data not shown). The effects of BK were fully reversible after a 10-to 20-min washout period. Time for recovery during washout was directly related to the concentration. No apparent desensitization was observed with repeated exposures at 10-to 20-min intervals. Bradykinin-evoked responses persisted when 300 nM tetrodotoxin was coapplied with BK in seven S-type neurons. Likewise, reduction of Ca 2ϩ to 0.5 mM and elevation of Mg 2ϩ to 12.5 mM in the bathing solution did not suppress the amplitude of BK-evoked depolarizing responses. Tetrodotoxin blocks generation of action potentials in ENS axons and the axonal release of neurotransmitters (Wood, 1994b) . Elevated Mg 2ϩ and reduced Ca 2ϩ prevent Ca 2ϩ entry into axon terminals and thereby suppress the release of neurotransmitters. Failure of tetrodotoxin or reduced Ca 2ϩ and elevated Mg 2ϩ to alter the excitatory responses to BK was indicative of a direct action at receptors on the ganglion cell rather than an indirect action due to exci- 
Concentration-Response Relations (S-Type Neurons).
Concentration-response relations for BK-evoked depolarizing responses were determined only for S-type neurons due to scarcity of AH-type neurons in the guinea pig submucosal plexus.
Threshold concentration for a measurable effect of BK on the membrane potential was 0.1 to 3 nM. The EC 50 was 2.7 Ϯ 0.4 nM for seven S-type neurons and the maximal depolarizing response was 18.2 Ϯ 2.5 mV (n ϭ 9 S-type neurons) evoked by 300 nM BK (Fig. 4, A and C) . The actions of the selective BK B 1 receptor antagonists des-arg 9 -leu 8 -BK and des-arg 10 -HOE-140 were compared with the actions of the selective BK B 2 receptor antagonists HOE-140 and a nonpeptide B 2 receptor antagonist, WIN64338. HOE-140 (1-300 nM) concentration dependently suppressed the depolarizing action of 30 nM BK with an IC 50 value of 31.0 Ϯ 6.0 nM for eight S-type neurons (Fig. 5, A-A 7 ) . The threshold concentration for HOE-140 was 1 to 3 nM. The action of HOE-140 was long-lasting, requiring up to 40 min of washout for full recovery. WIN64338 (0.1-3 M) also suppressed BK-evoked depolarization in concentration-dependent manner with an IC 50 value of 0.7 Ϯ 0.1 M in seven S-type neurons. The IC 50 value for WIN64338 was 20-fold higher than for HOE-140 (Fig. 5E ). Neither 300-nM des-arg 9 -leu 8 -BK in five ganglion cells nor 300 nM des-arg 10 -HOE-140 in seven ganglion cells suppressed BK-evoked responses. The selective BK B 2 receptor agonist kallidin (10 nM-3 M) acted to depolarize the membrane potential with an EC 50 value of 298.9 Ϯ 61.5 nM for five S-type neurons. On the other hand, the selective B 1 receptor agonist des-Arg 9 -BK was ineffective in concentrations of 1 to 3 M in nine neurons (Fig. 5C) .
Ionic Mechanisms. Depolarizing responses evoked by BK (0.3-300 nM) were associated with increased neuronal input resistance in 22 of 75 neurons and with decreased input resistance in 39 of 75 neurons. Input resistance was unchanged in 14 of 75 neurons. The input resistance was decreased or unchanged in S-type neurons with uniaxonal morphology and increased in AH-type neurons with multipolar morphology. Figure 6A shows the current-voltage (I-V) relationship for an S-type neuron in which the depolarizing responses to BK were associated with decreased input resistance. The I-V curves obtained in the absence and presence of BK intersected at 8 mV, which is the estimated reversal potential for the depolarizing response. The mean extrapolated reversal potential for the BK-evoked depolarizing responses associated with decreased input resistance was Ϫ10.8 Ϯ 8.4 mV (range Ϫ28 to ϩ10 mV) for five S-type neurons.
Application of BK by pressure microejection ("puffs") evoked slowly activating and prolonged depolarizing responses that were similar to responses evoked by bath application (n ϭ 10 neurons). No rapidly activating depolarizing responses similar to nicotinic responses to acetylcholine were ever observed. The prolonged depolarization in response to puffs of BK was associated with the firing of action potentials (n ϭ 7 neurons). The input resistance decreased in most of the neurons tested (6/10) with pressure microejection of 100 nM BK. The amplitude of the BK-evoked depolarizing responses that were associated with decreased input resistance increased when the membrane potential was currentclamped in the hyperpolarizing direction and decreased when the membrane potential was shifted in the depolarizing direction (Fig. 6, C and D) .
Electrophysiological behavior of this nature suggested that BK activates a cationic conductance in the S-type neurons. We tested this hypothesis by examining BK-evoked depolarizing responses in bathing solutions in which the concentration of Na ϩ was reduced by 82% by substitution of NaCl with N-methyl-D-glucamine or choline chloride. The membrane Fig. 4 . Depolarizing responses to bradykinin were concentration-dependent in guinea pig small intestinal submucosal neurons. A, responses to BK in concentrations from 0.3 to 300 nM in the same neuron. Downward deflections are electrotonic potentials evoked by intraneuronal injection of constant current hyperpolarizing pulses. Decreased amplitude of the downward deflections reflects decreased input resistance. Upward deflections are action potentials occurring at the offset of hyperpolarizing current pulses. Occurrence of action potentials reflects elevated neuronal excitability. Action potential amplitude is blunted by the low-frequency response of the chart recorder. B, concentration-response relationship for BK-evoked depolarizing responses. Data were obtained from seven S-type neurons. C, morphology of the uniaxonal neuron from which the records in A were obtained. potential was current-clamped at its original level before application of BK in the studies with reduced Na ϩ . In low Na ϩ solution, the amplitude of depolarizing responses evoked by 100 nM BK were reduced by 50.7 Ϯ 5.8% in seven S-type neurons. BK evoked no spike discharge in low Na ϩ solution (data not shown).
Suppression of Ca 2ϩ entry in bathing solutions containing 16 mM Mg 2ϩ and with Ca 2ϩ reduced from 2.5 mM to 1 mM did not significantly reduce the amplitude of the depolarizing responses to BK in S-type neurons. This suggested that the depolarizing responses to BK in S-type neurons might not be dependent on influx of extracellular Ca 2ϩ . Exposure to BK evoked membrane depolarization associated with increased input resistance in 22 AH-type neurons. An I-V relationship for an AH-type neuron in the presence and absence of BK is shown in Fig. 6B .
I-V curves obtained in the absence and presence of 30 nM BK intersected at Ϫ88 mV. The mean reversal potential for the depolarizing responses that were associated with increased input resistance was Ϫ92.0 Ϯ 4.5 mV (range Ϫ85 to Ϫ105 mV) for five AH-type neurons. These values are near the estimated equilibrium potential for K ϩ in enteric neurons and may reflect decreased K ϩ conductance during the depolarizing responses to BK in AH-type neurons (North, 1973) .
Discussion
Bradykinin is formed in inflammatory, ischemic and hemorrhagic conditions in the gut (Brown and Roberts, 2001) . It is a peptide cleaved from ␣ 2 globulins termed kininogens. Specific proteases called kallikreins release bradykinin from the kininogens (Bhoola et al., 1992 ). The present studies tested the suggestion that after intramural formation in the intestine, BK might act on the ENS as a paracrine mediator to alter neural control of secretory and motility functions at the organ level.
Excitation of ganglion cells in the submucosal plexus was found to be a primary action of bradykinin. Several lines of evidence suggested that the BK B 2 receptor was the exclusive mediator of the neuronal excitatory responses. No evidence The evidence is consistent with earlier published reports that the B 2 receptor is the sole receptor for BK in the guinea pig (Kachur et al., 1987; Pruneau et al., 1995) . A similar conclusion was reached for the mouse where knockout of the B 2 receptor eliminated all responses to BK in both in vivo and in vitro preparations (Borkowski et al., 1995; Seabrook et al., 1997) .
The B 2 receptor, unlike the B 1 receptor, is constitutively expressed in most tissues; B 1 receptors are not constitutively expressed. Bradykinin B 1 receptors are up-regulated by inflammation and cytokines (Dray and Perkins, 1993) . This leaves open the untested possibility that enteric neurons might be found to express the B 1 receptor if examined in intestinal inflammatory states.
Results from both electrophysiological and histological studies suggested that the majority of neuronal cell bodies in the ganglia expressed the B 2 receptor. Bradykinin selectively stimulated excitability in neurons that expressed immunoreactivity for VIP and/or ChAT. VIPergic and cholinergic neurons with S-type electrophysiological behavior and uniaxonal morphology in the submucosal plexus are known to function as secretomotor neurons (Brookes, 2001a,b) . Enhanced excitability in the population of secretomotor neurons elevates intestinal mucosal secretion of electrolytes, H 2 O, and mucus and can underlie the neurogenic secretory diarrhea often associated with inflammatory states and ischemia-reperfusion injury (Cooke, 2000) .
Exposure to BK evoked depolarizing responses in submucosal neurons with S-type electrophysiological behavior and uniaxonal morphology, and the depolarization was associated with decreased neuronal input resistance. A reversal potential near -10 mV for the depolarizing responses suggested that the underlying ionic mechanism for the responses in the S-type neurons might be opening of nonselective cationic conductance channels. Findings that the amplitude of the BK-evoked responses was reduced in bathing solution with reduced Na ϩ and remained unaffected in solutions with reduced Ca 2ϩ and elevated Mg 2ϩ were consistent with elevated Na ϩ (and perhaps K ϩ ) conductance being the ionic mechanism for the depolarizing responses. The responses to BK in S-type neurons were similar to reported actions for substance P, serotonin, and acetylcholine in the submucosal plexus, which were interpreted by Shen and Surprenant (1993) to be due to an increase in a cation-selective ("mainly sodium") conductance.
AH-type neurons were not a primary focus for the present study because their numbers in the submucosal plexus were less than 10% of the neuronal population. Nevertheless, both direct and indirect immunofluorescence studies confirmed the expression of BK B 2 receptors by submucosal neurons with a combination of AH-type electrophysiological behavior, multipolar morphology, and double labeling with calbindin, which is a chemical code for AH-type neurons in the guinea pig ENS. Bradykinin evoked depolarizing responses in the AH-type neurons and the depolarization was associated with increased neuronal input resistance and reduction in amplitude of the characteristic long-lasting hyperpolarizing afterpotentials in these neurons. The mean reversal potential for the depolarizing responses to BK in AH-type neurons was -92 mV and was characteristic of the depolarizing responses reported for the action of other excitatory mediators (e.g., Fig. 6 . Reversal potentials for bradykinin-evoked depolarizing responses differed for S-and AH-type submucosal neurons. A, current-voltage relationship for an S-type neuron in the presence and absence of 30 nM bradykinin. Reduced slope of the curve for bradykinin reflects decreased input resistance. Intersection of the two curves at a membrane potential of Ϸ10 mV reflects the reversal potential. B, current-voltage relationship for an AHtype neuron in the presence and absence of 30 nM BK. Increased slope of the curve for bradykinin reflects increased input resistance. Intersection of the two curves at a membrane potential of approximately Ϫ92 mV reflects the reversal potential. C, micropressure application of 100 nM bradykinin (puffs) evoked slowly activating membrane depolarization in an S-type neuron. The amplitude of the depolarizing responses progressively decreased as the resting membrane potential was current-clamped in the depolarizing direction starting at -83 mV and continuing in steps that stopped at 23 mV. D, data obtained from four S-type neurons in which the depolarizing responses to bradykinin were associated with decreased input resistance. The data extrapolate to a reversal potential between -20 and 20 mV (mean ϭ 6.5 Ϯ 8.6 mV). histamine, substance P, and serotonin) on AH-type neurons (Katayama and North, 1978; Wood and Mayer, 1979; Nemeth et al., 1984) . The reversal potential of -92 mV in AH-type neurons was close to the estimated K ϩ equilibrium potential and suggestive of decreased K ϩ conductance as the ionic mechanism underlying the depolarizing responses. Suppression of the hyperpolarizing after-potenials in AH-type neurons by BK was also characteristic for the action reported for other excitatory mediators, including substance P, histamine, and serotonin (Katayama and North, 1978; Wood and Mayer, 1979; Nemeth et al., 1984) .
Bradykinin seems not to be an excitatory neurotransmitter in the submucosal plexus because there is no evidence that BK is stored and released by the ganglion cells. On the other hand, BK-containing neurons were reported to be present in the central nervous system (Correa et al., 1979) . Our evidence overall suggests that BK behaves solely as a paracrine mediator in the ENS with excitatory actions on both S-and AH-type neurons in the submucosal plexus. The S-type neurons are primarily secretomotor neurons that receive excitatory synaptic input from their AH-type neighbors (Cooke, 2000) . Enhanced excitability in both populations of submucosal neurons by BK is a mechanistic explanation for reports of stimulated mucosal secretion during exposure to BK (Kachur et al., 1987; Gaginella and Kachur, 1989) . The pathophysiological significance of the neuronal actions of BK can therefore be related to the secretory diarrhea associated with intestinal inflammatory states in which the BK levels increase and the BK B 2 receptor is overexpressed (Stadnicki et al., 1998) .
